DNMT3A and acute myeloid leukemia: Current knowledge on the clonal architecture of NPM1m AML shows that NPM1 mutation is often sub-clonal to DNMT3A, IDH1/2, or TET2 mutations, which can pre-exist as clonal hematopoiesis of indeterminate potential [12,13].